Manufacturing
Laennec® manufacturing is controlled in Japan at the State level by the State program for improvement of the nation's health. Subsidies and supervision is carried out by the Japanese Medical Department.
Not every placenta is suitable for a manufacturing of LAENNEC.
• Placenta is taken only if a birth was successful, pregnancy period was full and expectant new mother never left Japan.
• Prospective donors give in advance their written consent to the use placenta and are checked for the presence of any sexually transmitted, infectious and other diseases.
• Medical surveillance of a donor is carried out prior to birth and during 6 months thereafter.
• Placenta is tested several times in fresh and frozen form within 6 months.
• It must meet high requirements for the content of viruses and germs.
• Placental extract is disinfected in special conditions in order to destroy the yet unknown microorganisms and bacteria that may be present in it and cannot be determined by tests.
In addition to disinfection, the raw material for LAENNEC manufacturing is cleaned at the molecular level from prion and structural proteins, protein components of blood, stem cells and hormones.
Technology of multi-molecular fractionation with special filters is used for these purposes.
Due to use of high-tech placenta extraction method with molecular marking (filter) LAENNEC formulation is completely free of potentially dangerous substances.
Composition:
•Vitamins;
•Minerals;
•Amino acids;
•Peptides.
Application:
•Support and reconstitution of liver and other organs and systems;
•Treatment of various pathologies;
•Recovery and rejuvenation of body.
It is administered via intravenous or intramuscular injections, or intradermal injections in certain biologically active points.